NDC 51645-850

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each

Docusate Sodium,sennosides

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Gemini Pharmaceuticals, Inc. Dba Plus Pharma. The primary component is Docusate Sodium; Sennosides.

• Product ID: 51645-850_6fa306a8-b1c3-25e5-e053-2a91aa0a4851
• NDC: 51645-850
• Product Type: Human Otc Drug
• Proprietary Name: Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each
• Generic Name: Docusate Sodium,sennosides
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2006-03-27
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: Gemini Pharmaceuticals, Inc. dba Plus Pharma
• Substance Name: DOCUSATE SODIUM; SENNOSIDES
• Active Ingredient Strength: 50 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51645-850-06

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51645-850-06)

• Marketing Start Date: 2006-03-27
• Marketing End Date: 2022-03-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51645-850-09 [51645085009]

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2006-03-27
• Marketing End Date: 2015-01-06

NDC 51645-850-01 [51645085001]

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2006-03-27

NDC 51645-850-10 [51645085010]

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2006-03-27

NDC 51645-850-99 [51645085099]

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2006-03-27

NDC 51645-850-06 [51645085006]

Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each TABLET, FILM COATED

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2006-03-27

Drug Details

Active Ingredients

Ingredient	Strength
DOCUSATE SODIUM	50 mg/1

OpenFDA Data

• SPL SET ID: 55e6350a-cdeb-4aba-9f7a-d9ddf7c1b3cf
• Manufacturer:
  • Gemini Pharmaceuticals, Inc. dba Plus Pharma
• UNII:
  • F05Q2T2JA0
  • 3FYP5M0IJX
• RxNorm Concept Unique ID - RxCUI:
  • 998740

Medicade Reported Pricing

51645085099 SENNA PLUS TABLET

Pricing Unit: EA | Drug Type:

51645085010 SENNA PLUS TABLET

Pricing Unit: EA | Drug Type:

51645085006 SENNA PLUS TABLET

Pricing Unit: EA | Drug Type:

51645085001 SENNA PLUS TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Plus Pharma Senna Plus Standardized Senna Concentrate 8.6 mg and Docusate Sodium 50 mg Each" or generic name "Docusate Sodium,sennosides"

NDC	Brand Name	Generic Name
69975-850	Colistat Plus	DOCUSATE SODIUM,SENNOSIDES
51645-850	Plus Pharma Senna Plus	DOCUSATE SODIUM,SENNOSIDES
45865-938	Senna Plus	DOCUSATE SODIUM,SENNOSIDES